Introduction
============

Achalasia is an uncommon primary esophageal motor disorder that is defined by lack of peristalsis in the smooth muscle esophagus and failed or insufficient relaxation of the lower esophageal sphincter (LES) in response to swallowing.[@b1-jnm-23-378]

Frequently, gastroenterologists in referral centers see patients with achalasia who were previously diagnosed with gastroesophageal reflux disease (GERD) based on symptoms, but who did not respond to proton pump inhibitor (PPI) treatment. This is likely because while both disorders can present with similar symptoms, GERD is more common, making it the default diagnosis for a practitioner with limited awareness and knowledge of achalasia. In addition, achalasia has an insidious onset and progresses gradually, giving the illusion that it is a chronic but stable condition. Therefore, patients with achalasia typically experience symptoms for years before diagnosis. A previous report showed that the mean duration of symptoms prior to diagnosis was 4.7 years in patients with newly diagnosed achalasia.[@b2-jnm-23-378] The delay in diagnosis was mainly because typical symptoms like heartburn and regurgitation were misinterpreted as GERD. Stasis of food with acidic content is frequently misunderstood as the acid regurgitation of GERD, and fermentation can cause heartburn. This leads many patients to being treated for GERD well before the diagnosis of achalasia is made.[@b3-jnm-23-378] Having said this, it is not known how often the presence of symptoms erroneously leads to treatment with a PPI on the assumption that GERD is present.

The aim of this study is to evaluate the clinical, radiologic, and manometric findings of our patients with untreated achalasia.

Materials and Methods
=====================

Patients
--------

The clinical records of patients with achalasia at Gangnam Severance Hospital in Seoul, Korea, between July 2004 and January 2012, were retrospectively collected. The diagnosis of achalasia was based on the results of clinical evaluation with barium esophagram, endoscopy, esophageal transit scintigraphy (ETS), and esophageal manometry. None of the patients had underwent previous endoscopic treatment (botulinum toxin injection or pneumatic dilatation) or surgical myotomy at the time of their evaluation for this study.

This was a retrospective study from a prospectively collected database. The data were stored in paper form. Questionnaires (including dysphagia grade and the Eckardt score) were updated at the time of diagnosis. In particular, we checked whether patients were taking PPI because their primary physician had presumed their symptoms were caused by refractory GERD. The definition of refractory GERD remains controversial.[@b4-jnm-23-378]--[@b6-jnm-23-378] Refractory GERD was defined as the persistence of symptoms that do not respond to standard dose of PPI once daily during a treatment period of at least 8 weeks. Patients with achalasia were excluded if they had a previous treatment history of botulinum toxin injection, pneumatic dilatation or surgical myotomy. This study had Institutional Review Board approval of Gangnam Severance Hospital.

Symptom Evaluation
------------------

Patients were assessed using the Eckardt score[@b7-jnm-23-378] and dysphagia grade. The Eckardt score is derived from several symptom scores for dysphagia, regurgitation, and chest pain (0, absent; 1, occasional; 2, daily; and 3, each meal), and weight loss (0, no weight loss; 1, \< 5 kg; 2, 5--10 kg; and 3, \> 10 kg). The scores from each symptom are summed to make a total score that ranges from 0 to 12 points. The heartburn was categorized into 4 groups according to symptom frequency (0, absent; 1, occasional; 2, daily; and 3, each meal). The duration of symptoms was also recorded. The dysphagia grade was categorized into five groups according to the severity of the dysphagia (1 indicates dysphagia to meat; 2, to rice; 3, to semi-solid diet; 4, to a liquid diet; and 5 to water).

Esophagram
----------

Esophagram was performed in the erect anteroposterior projection, as well as the erect left posterior and anterior oblique fluoroscopic projections (Shimavision 2000HG; Shimadzu, Kyoto, Japan). The shape of the esophagus, its maximum diameter, narrowing at the esophagogastric junction, and the presence of diverticula were recorded. Two gastrointestinal radiologists reviewed all measurements, and a consensus was reached.

Esophageal Transit Scintigraphy
-------------------------------

ETS was performed with technetium-99m after overnight fasting. All ETS images were acquired using a gamma camera (Genesys Vertex; Adac Laboratories, CA, USA) and an anterior scan with the patient in the erect position. The time-radioactivity curve was made using the method described in a previous study.[@b8-jnm-23-378] The time required for radioactivity in the esophagus to reach half of the maximum was defined as the half time (*T*~1/2~). The residual fraction of maximum radioactivity in the esophagus at 30 seconds was defined as *R*~30~ (%).

Esophageal Manometry
--------------------

Esophageal manometry was performed using an eight-channel water perfusion system from Synectics Medical Carsen Group (Washington, USA) from 2002 to 2010. After 2011, esophageal manometry was performed by high-resolution manometry (HRM) with a 21-channel manometric assembly from Sierra Scientific Instruments (Los Angeles, CA, USA). The data were digitized and displayed, stored, and analyzed using Mano View analysis software from Sierra Scientific Instruments. Each manometry procedure was performed as previously described.[@b8-jnm-23-378]

Achalasia was diagnosed by conventional manometry when there was a lack of peristalsis in the smooth muscle esophagus and when failed or insufficient relaxation of the LES was present. Achalasia was diagnosed by HRM when the integrated relaxation pressure was 15 or greater and there was no peristalsis in the smooth muscle of the esophagus. Of the total number of patients in our study, only 47 patients had undergone esophageal manometry tests, 39 patients of which were tested by conventional manometry, and 8 patients by HRM.

Statistical Methods
-------------------

Frequency, percentage, and median (interquartile range) were used as descriptive statistics. Chi-square tests or Fisher's exact test were used to compare categorical variables. Continuous variables are presented as medians and were compared using a Mann-Whitney U test. Differences were considered significant at a *P*-value of less than 0.05. All statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) 18.0 for Windows (IBM Corp, Armonk, NY, USA).

Results
=======

Patient Characteristics
-----------------------

This study included a total of 64 patients (36 female and 28 male) with primary achalasia. Clinical, radiographic, and manometric data of the patients are provided in [Table 1](#t1-jnm-23-378){ref-type="table"}. All 64 patients had dysphagia, with the median dysphagia grade being 3 (2--4), and the median duration of symptoms was 23.5 (interquartile range, 5.3--57.0) months. Other symptoms at the time of presentation were regurgitation (76.6%), chest pain (54.7%), heartburn (59.4%), and weight loss (68.7%). The median Eckardt score was 5 (3--7). At the time of referral to our center, 16 patients (25.0%) were taking a PPI on the assumption by the referring physician that refractory GERD was the cause of their symptoms. Persistence of symptoms and poor response despite PPI therapy, and/or endoscopic findings not consistent with symptoms were the main indications for referral to our tertiary care center. Endoscopy was performed in all patients. No patients had Barrett's esophagus, stricture, or cancer.

Sixty-one patients (95.3%) underwent barium esophagram. The other 3 patients could not hold a sufficient mouthful of barium to ensure adequate swallow volumes. The median maximum diameter of the esophageal body was 44 mm (38--52). A dilated and tortuous esophagus was present in 6 patients (9.4%). Diverticulae were present in 2 patients (3.1%).

Forty-seven patients were diagnosed by esophageal manometry. Thirty-nine patients who received conventional manometry had a median LES pressure of 44.3 mmHg (28.1--71.1). Eight patients who received HRM had a median resting LES pressure of 37.1 mmHg (22.8--64.2). The other 17 patients were diagnosed by barium esophagram, either because they could not tolerate the manometry catheter or because the catheter could not be placed due to esophageal dilatation and tortuosity of the lower esophagus.

Fifty-seven patients received ETS. The median *T*~1/2~ for esophageal emptying was 22.5 (4.7--503.8) minutes. The median *R*~30~ was 64% (41.5--83.5%).

Comparison of Clinical, Radiographic, and Manometric Findings in Relation to Heartburn Symptoms
-----------------------------------------------------------------------------------------------

Comparison of clinical, radiographic, and manometric findings according to the presence or absence of heartburn symptoms showed that age, sex, duration of symptoms, dysphagia, dysphagia grade, and PPI use were similar between the 2 groups ([Table 2](#t2-jnm-23-378){ref-type="table"}). Patients with heartburn symptoms were more likely to exhibit weight loss ≥ 5 kg (*P* = 0.009), daily regurgitation (*P* = 0.001), and daily chest pain (*P* = 0.019). They also had a higher Eckardt score (*P* \< 0.001). However, there were no statistically significant differences between the groups with regard to other factors.

Comparison of Clinical, Radiographic, and Manometric Findings in Relation to Proton Pump Inhibitor Use
------------------------------------------------------------------------------------------------------

We compared the clinical, radiographic, and manometric findings in relation to erroneous GERD diagnosis based on the use of PPI on the assumption by the referring physician as refractory GERD ([Table 3](#t3-jnm-23-378){ref-type="table"}). The PPI-treated group was defined as standard dose of PPI once daily treatment for at least 8 weeks. There were no statistically significant differences between the groups for any of the variables tested, including duration of symptoms.

Discussion
==========

The major findings of our study in patients with untreated achalasia are as follows. First, dysphagia was the most common complaint, although regurgitation and heartburn were also frequently present. The prevalence of heartburn in our patients with achalasia was 59.4%, which is higher than that reported elsewhere.[@b9-jnm-23-378]--[@b11-jnm-23-378] It is generally thought that the diagnosis of GERD can be reliably made on the basis of clinical symptoms: if a patient has heartburn or regurgitation it is assumed that acid reflux is present, and therefore a PPI is prescribed. However, symptoms are less sensitive and specific than commonly believed. A previous study showed that symptoms alone cannot distinguish real GERD from other disorders.[@b12-jnm-23-378] Patients with achalasia frequently complain of regurgitation and heartburn. In untreated patients, postprandial stasis and fermentation of food in the esophagus due to impaired esophageal emptying are thought to cause these symptoms.[@b13-jnm-23-378]--[@b15-jnm-23-378] Additionally, dysphagia is frequently reported by patients with GERD.[@b16-jnm-23-378] Therefore, achalasia can be erroneously diagnosed as GERD.

Second, achalasia patients with heartburn were more likely to experience weight loss, regurgitation, and chest pain. These patients might have more prominent postprandial stasis, fermentation of food and poor esophageal clearance, which cause pseudo-gastroesophageal reflux.[@b13-jnm-23-378]--[@b15-jnm-23-378],[@b17-jnm-23-378] A previous study showed a high prevalence of heartburn in achalasia patients, although objective evidence of GERD was weak.[@b18-jnm-23-378] Another study suggested that other processes such as esophageal muscle spasm, ischemia, or esophageal distension might account for the heartburn and chest pain in patients with achalasia.[@b19-jnm-23-378] Weight loss of between 5 and 10 kg occurs in many, but not all, achalasia patients. Our patients with heartburn were more likely to have weight loss of ≥ 5 kg than those without heartburn. Perhaps it is the regurgitation and chest pain that are more likely in patients with heartburn, which have a negative influence on the dietary intake of achalasia patients.

Third, the median duration of symptoms at the time of diagnosis of achalasia was 23.5 months. This is different from the findings of several previous studies in which the mean duration of symptoms at diagnosis was greater than 4 years.[@b2-jnm-23-378],[@b20-jnm-23-378] Achalasia has an insidious onset and disease progression is gradual, therefore patients typically experience symptoms for years prior to seeking medical care. Previous studies concluded that the delay in diagnosis was due to misinterpretation as GERD based on typical clinical findings of achalasia. Many patients are treated for GERD before the diagnosis of achalasia[@b3-jnm-23-378],[@b17-jnm-23-378]; indeed, 25% of patients in this study were treated with PPIs for relief of symptoms. However, the duration of symptoms was shorter in our patient population than in other studies, and misdiagnosis as GERD was not a major factor in the delay of diagnosis of achalasia. There are several possible reasons for these differences. Endoscopy is inexpensive and widely available in Korea, even in primary care clinics. Because endoscopy is available in almost all regions of Korea, other diseases such as GERD or esophageal cancer can be excluded on endoscopy. Most patients who present with heartburn, epigastric pain, regurgitation, and dysphagia initially undergo an endoscopic examination. Furthermore, the medical care and services, including manometry, that are provided by tertiary hospitals are very accessible in almost all areas of Korea. Consequently, manometry was used early to evaluate patients with symptoms who had not responded to PPI therapy and had non-specific findings on endoscopy. Our findings support the medical statement of the American Gastroenterological Association that manometry should be used to evaluate patients with suspected GERD who do not respond to PPI therapy and have normal findings on endoscopy.[@b21-jnm-23-378]

There are some limitations in this study. First, it was a retrospective study in a single tertiary hospital. Second, the sample size was relatively small because achalasia is rare, which makes it difficult to enroll a large population. Third, this study used univariate analysis.

In conclusion, the clinical presentation of patients with untreated achalasia can show overlap with those of patients with GERD. Therefore, these findings suggest that achalasia should be suspected in patients with refractory GERD.
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###### 

Baseline Patient Characteristics

  ---------------------------------------------------------------------------- -----------------------
  Total patients                                                               64
  Age (median \[IQR\], yr)                                                     44.5 (31.5--54.0)
  Duration of symptoms (median \[IQR\], mo)                                    23.5 (5.3--57.0)
  Sex (female/male, n)                                                         36 (56.3%)/28 (43.7%)
  Weight loss (n)                                                              
   0 kg                                                                        20 (31.3%)
   \< 5 kg                                                                     25 (39.1%)
   5--10 kg                                                                    17 (26.6%)
   \> 10 kg                                                                    2 (3.0%)
  Dysphagia (n)                                                                
   No                                                                          0 (0.0%)
   Occasionally                                                                15 (23.4%)
   Every day                                                                   21 (32.8%)
   Several times/day                                                           28 (43.8%)
  Regurgitation (n)                                                            
   No                                                                          15 (23.4%)
   Occasionally                                                                26 (40.7%)
   Every day                                                                   18 (28.1%)
   Several times/day                                                           5 (7.8%)
  Chest pain (n)                                                               
   No                                                                          29 (45.3%)
   Occasionally                                                                24 (37.5%)
   Every day                                                                   7 (10.9%)
   Several times/day                                                           4 (6.3%)
  Heartburn (n)                                                                
   No                                                                          26 (40.6%)
   Occasionally                                                                27 (42.2%)
   Every day                                                                   9 (14.1%)
   Several times/day                                                           2 (3.1%)
  Dysphagia grade (n)                                                          
   Meat                                                                        4 (6.3%)
   Rice                                                                        21 (32.8%)
   Semisolid                                                                   17 (26.6%)
   Liquid                                                                      15 (23.4%)
   All                                                                         7 (10.9%)
  Eckardt score (median \[IQR\])                                               5 (3--7)
  Proton pump inhibitor use (n)                                                16 (25.0%)
  Esophagram (median \[IQR\], mm)                                              
   Maximum diameter of the esophageal body                                     44 (38--52)
  Manometry[a](#tfn1-jnm-23-378){ref-type="table-fn"} (median \[IQR\], mmHg)   
   LES pressure of conventional manometry                                      44.3 (28.1--71.1)
   LES pressure of high-resolution manometry                                   37.1 (22.8--64.2)
  Esophageal scan[b](#tfn2-jnm-23-378){ref-type="table-fn"}                    
   *T*~1/2~ (median \[IQR\], min)                                              22.5 (4.7--503.8)
   *R*~30~ (median \[IQR\], %)                                                 64.0 (41.5--83.5)
  ---------------------------------------------------------------------------- -----------------------

Only 47 patients were tested by esophageal manometry (39 conventional manometry and 8 high-resolution manometry).

Fifty-seven patients were examined by esophageal scan.

IQR, interquartile range; LES, lower esophageal sphincter; *T*~1/2~, half time of esophageal transit scintigraphy; *R*~30~, the residual fraction of maximum radioactivity in the distal esophagus after 30 seconds.

###### 

Comparison of Clinical, Radiographic, and Manometric Profiles in Relation to Heartburn Symptoms

                                                                                   Heartburn symptoms (n = 38)   No heartburn symptoms (n = 26)   *P*-value
  -------------------------------------------------------------------------------- ----------------------------- -------------------------------- -----------
  Age (median \[IQR\], yr)                                                         41.0 (33.8--54.3)             47.0 (30.8--53.5)                0.848
  Sex (female/male, n)                                                             19 (50.0%)/19 (50.0%)         17 (65.4%)/9 (34.6%)             0.223
  Duration of symptoms (median \[IQR\], mo)                                        17.5 (5.0--69.0)              30 (5.5--54.0)                   0.768
  Weight loss (n)                                                                                                                                 
   \< 5 kg/≥ 5 kg                                                                  22 (57.9%)/16 (42.1%)         23 (88.5%)/3 (11.5%)             0.009
  Dysphagia (n)                                                                                                                                   
   \< Occasionally/≥ every day                                                     7 (18.4%)/31 (81.6%)          8 (30.8%)/18 (69.2%)             0.252
  Regurgitation (n)                                                                                                                               
   \< Occasionally/≥ every day                                                     18 (47.4%)/20 (52.6%)         23 (88.5%)/3 (11.5%)             0.001
  Chest pain (n)                                                                                                                                  
   \< Occasionally/≥ every day                                                     28 (73.7%)/10 (26.3%)         25 (96.2%)/1 (3.8%)              0.019
  Proton pump inhibitor use (n)                                                    12 (31.6%)                    4 (15.4%)                        0.142
  Dysphagia grade (n)                                                                                                                             
   1--2/3--5                                                                       14 (36.8 %)/24 (63.2%)        11 (42.3%)/15 (57.7%)            0.660
  Eckardt score (median \[IQR\])                                                   6 (4.0--7.3)                  3 (2.0--4.3)                     \< 0.001
  Esophagram (median \[IQR\], mm)                                                                                                                 
   Maximum diameter of the esophageal body                                         46.0 (38.0--54.0)             40.0 (36.0--51.2)                0.206
  Conventional manometry                                                                                                                          
   LES pressure (median \[IQR\], mmHg)[a](#tfn4-jnm-23-378){ref-type="table-fn"}   42.7 (25.8--57.8)             57.4 (32.3--109.2)               0.175
  High-resolution manometry                                                                                                                       
   LES pressure (median \[IQR\], mmHg)[b](#tfn5-jnm-23-378){ref-type="table-fn"}   43.2 (17--43.2)               31 (23.6--77)                    0.881
  Esophageal scan[c](#tfn6-jnm-23-378){ref-type="table-fn"}                                                                                       
   *T*~1/2~ (median \[IQR\], min)                                                  27.9 (4.3--499.5)             17.8 (4.4--1144)                 0.949
   *R*~30~ (median \[IQR\], %)                                                     60 (45--76)                   66 (36.8--87.3)                  0.558

Thirty-nine patients were examined by conventional manometry.

Eight patients were examined by high-resolution manometry.

Fifty-seven patients were examined by esophageal scan.

IQR, interquartile range; LES, lower esophageal sphincter; *T*~1/2~, half time of esophageal transit scintigraphy; *R*~30~, the residual fraction of maximum radioactivity in the distal esophagus after 30 seconds.

###### 

Comparison of Clinical, Radiographic, and Manometric Profiles in Relation to Proton Pump Inhibitor Use

                                                                                    PPI-treated group[a](#tfn8-jnm-23-378){ref-type="table-fn"} (n = 16)   PPI untreated group (n = 48)   *P*-value
  --------------------------------------------------------------------------------- ---------------------------------------------------------------------- ------------------------------ -----------
  Age (median \[IQR\], yr)                                                          41.5 (35.3--56.3)                                                      45.5 (31--53.8)                0.614
  Sex (female/male, n \[%\])                                                        6 (37.5%)/10 (62.5%)                                                   30 (62.5%)/18 (37.5%)          0.080
  Duration of symptoms (median \[IQR\], mo)                                         11 (6.26--33)                                                          24 (5--90)                     0.469
  Weight loss (n)                                                                                                                                                                         
   \< 5 kg/≥ 5 kg                                                                   12 (75%)/4 (25%)                                                       33 (68.8%)/15 (31.2%)          0.636
  Dysphagia                                                                                                                                                                               
   \< Occasionally/≥ every day                                                      4 (25%)/12 (75%)                                                       11 (22.9%)/37 (77.1%)          0.865
  Regurgitation n)                                                                                                                                                                        
   \< Occasionally/≥ every day                                                      10 (62.5 %)/6 (37.5%)                                                  31 (64.6%)/17 (35.4%)          0.880
  Chest pain (n)                                                                                                                                                                          
   \< Occasionally/≥ every day                                                      12 (75%)/4 (25%)                                                       41 (85.4%)/7 (14.6%)           0.339
  Heart burn (n)                                                                                                                                                                          
   \< Occasionally/≥ every day                                                      12 (75%)/4 (25%)                                                       41 (85.4%)/7 (14.6%)           0.339
  Dysphagia grade (n)                                                                                                                                                                     
   1--2/3--5                                                                        6 (37.5%)/10 (62.5%)                                                   19 (39.6%)/29 (60.4%)          0.882
  Eckardt score (median \[IQR\])                                                    5.5 (4--7.8)                                                           4.5 (3--7)                     0.407
  Esophagram (median \[IQR\], mm)                                                                                                                                                         
   Maximum diameter of the esophageal body                                          44.0 (38.1--51.5)                                                      44.0 (36.3--53)                0.694
  Conventional manometry                                                                                                                                                                  
   LES pressure (median \[IQR\], mmHg)[b](#tfn9-jnm-23-378){ref-type="table-fn"}    42.7 (28.1--73)                                                        45.0 (26.9--69)                0.888
  High-resolution manometry                                                                                                                                                               
   LES pressure (median \[IQR\], mmHg)[c](#tfn10-jnm-23-378){ref-type="table-fn"}   25.2 (22--25.2)                                                        59 (24--81)                    0.393
  Esophageal scan[d](#tfn11-jnm-23-378){ref-type="table-fn"}                                                                                                                              
   *T*~1/2~ (median \[IQR\], min)                                                   12.3 (5--140.4)                                                        22.6 (4.3--948)                0.270
   *R*~30~ (median \[IQR\], %)                                                      58 (38.8--77.8)                                                        65 (41--87)                    0.572

Standard dose proton pump inhibitor (PPI) once daily treatment during at least 8 weeks.

Thirty-nine patients were examined by conventional manometry.

Eight patients were examined by high-resolution manometry.

Fifty-seven patients were examined by esophageal scan.

IQR, interquartile range; LES, lower esophageal sphincter; *T~1/2~*, half time of esophageal transit scintigraphy; *R~30~*, the residual fraction of maximum radioactivity in the distal esophagus after 30 seconds.
